Results 61 to 70 of about 183 (86)

Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement. [PDF]

J Scleroderma Relat Disord
Sander L, Foeldvari I, Glaser D, Klotsche J, Stier R, Roldán JC.   +5 more
europepmc   +1 more source

Cervical Spine Involvement in Morphea Patients With Subclinical Neurologic Signs. [PDF]

Cureus
Critelli M, Davis T, Flume H, Sarameh Y, Baer CB, Shabbir R, Schwartz JT.   +6 more
europepmc   +1 more source

An Evaluation of the Performance of Current Morphea Subtype Classifications.

JAMA Dermatol, 2021
Prasad S, Zhu JL, Schollaert-Fitch K, Torok KS, Jacobe HT.   +4 more
europepmc   +1 more source

A Report of a Case of Reactivation of Plaque Morphea After Sunlight Exposure and a Literature Review. [PDF]

Cureus
Ivanova Z.
europepmc   +1 more source

Changes in Disease Activity and Damage Over Time in Patients With Morphea.

JAMA Dermatol, 2020
O'Brien JC, Nymeyer H, Green A, Jacobe HT.   +3 more
europepmc   +1 more source

What Is New in Morphea-Narrative Review on Molecular Aspects and New Targeted Therapies. [PDF]

J Clin Med
Stein T, Cieplewicz-Guźla P, Iżykowska K, Pieniawska M, Żaba R, Dańczak-Pazdrowska A, Polańska A.   +6 more
europepmc   +1 more source

Tracking Fat Grafts by Magnetic Resonance Imaging: A Comparative Study of Adolescent and Adult Patients with Stable Localized Scleroderma. [PDF]

Plast Reconstr Surg
Ma X, Wang L, Li T, Li Z, Chen Y, Wang T, Long X, Huang J, Wang X.   +8 more
europepmc   +1 more source

National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients. [PDF]

J Scleroderma Relat Disord
Branton SA, Stubbs LA, Havrilla HJ, Torok KS.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

AI-Assisted Body-Region Recognition for Localized Scleroderma: A Foundational Step Towards Automated LoSCAT scoring

Background: Localized scleroderma (LS) is a chronic inflammatory skin disease that can cause long-term functional and cosmetic morbidity, particularly in children. The Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) is the standard for clinical evaluation but remains manual and time-intensive.
Yuanyuan Cao, Chongyue Zhao, Elena Derosasa, Claire Ding, Yiwen Zhang, Kathryn S. Torok, Wei Chen   +6 more
openaire   +1 more source

POS1304 CORRELATION OF SKIN SCORES (LoSCAT) WITH PATIENT REPORTED OUTCOMES IN JUVENILE LOCALISED SCLERODERMA

Annals of the Rheumatic Diseases, 2022
C. Pain, A. Murray, G. Dinsdale, A. Marsden, J. Manning, A. Herrick   +5 more
openaire   +1 more source